The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

The main aim of this study was to evaluate the ability of serum biomarkers to predict the worsening of retinal neurodysfunction in subjects with type 2 diabetes. For this purpose, we measured selected molecules (N-epsilon-carboxy methyl lysine (CML), laminin P1 (Lam-P1), and asymmetric dimethylargin...

Full description

Bibliographic Details
Main Authors:	Cristina Hernández, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon P. Harding, Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, José Cunha-Vaz, Rafael Simó
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Journal of Clinical Medicine
Subjects:	diabetic retinopathy retinal neurodegeneration serum biomarkers laminin carboxy methyl lysine asymmetric dimethylarginine
Online Access:	https://www.mdpi.com/2077-0383/9/4/1233

Similar Items

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria
by: Rajkishor Nishad, et al.
Published: (2021-07-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
by: Laura Dowsett, et al.
Published: (2020-09-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)

Involvement of the receptor for advanced glycation end products in liver transplantation
by: Teresa Navarra, et al.
Published: (2015-03-01)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis
by: R.M. Catarino, et al.
Published: (2005-02-01)

Observing Dynamic Conformational Changes within the Coiled-Coil Domain of Different Laminin Isoforms Using High-Speed Atomic Force Microscopy
by: Lucky Akter, et al.
Published: (2024-02-01)

Association between Newly Diagnosed Essential Hypertension, Smoking, Assymetric Dimethylarginine and ischemia-Modified Albumin
by: Emine Altuntaş, et al.
Published: (2017-06-01)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
by: Joanna Piechowicz, et al.
Published: (2022-08-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-09-01)

Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications
by: Linfeng Chen, et al.
Published: (2023-09-01)

Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway
by: Iwona Bednarz-Misa, et al.
Published: (2020-08-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

Serum symmetric dimethylarginine in older dogs: Reference interval and comparison of a gold standard method with the ELISA
by: Sofie Marynissen, et al.
Published: (2024-03-01)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
by: Iwona Bednarz-Misa, et al.
Published: (2020-06-01)

Clinical Evaluation of Extracellular ADMA Concentrations in Human Blood and Adipose Tissue
by: Marcus May, et al.
Published: (2014-01-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

ADMA, SDMA and L-arginine may be novel targets in pharmacotherapy for complications due to cardiopulmonary bypass
by: Kahraman Aydin, et al.
Published: (2017-01-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
by: Dimitrios Tsikas
Published: (2020-06-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Nitric Oxide Metabolites and Asymmetric Dimethylarginine Concentrations in Breast Milk
by: Hakan Öztürk, et al.
Published: (2017-04-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
by: Avci Emre, et al.
Published: (2020-01-01)

The role of L-arginine in the pathogenesis of essential arterial hypertension
by: V. A. Shcherbak, et al.
Published: (2024-03-01)

Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway
by: Dong Chen, et al.
Published: (2017-01-01)

Ultrasonographic Assessment of the Cutaneous Changes Induced by Topical Use of Novel Peptides Comprising Laminin 5
by: Kyong Chan Park, et al.
Published: (2022-05-01)

Influence of Laminin Coating on the Autologous In Vivo Recellularization of Decellularized Vascular Protheses
by: Mahfuza Toshmatova, et al.
Published: (2019-10-01)